Starting in 2023, the cost of a one-month supply of each Part D-covered insulin will be capped at $35, and patients will not have to pay a deductible for insulin. This applies to everyone who takes insulin.
For insulin used with a traditional insulin pump that is covered under the Medicare durable medical equipment benefit, patients pay 20% of the Medicare-Approved Amount after they meet the Part B deductible. Patients pay 100% for insulin-related supplies (like syringes, needles, alcohol swabs, and gauze), unless they have Part D.
Click here to read more.